Bevacizumab and Rucaparib in Recurrent Carcinoma of the Cervix or Endometrium
about
Bevacizumab and Rucaparib in Recurrent Carcinoma of the Cervix or Endometrium
description
clinical trial
@en
klinisch onderzoek
@nl
name
Bevacizumab and Rucaparib in Recurrent Carcinoma of the Cervix or Endometrium
@en
type
label
Bevacizumab and Rucaparib in Recurrent Carcinoma of the Cervix or Endometrium
@en
prefLabel
Bevacizumab and Rucaparib in Recurrent Carcinoma of the Cervix or Endometrium
@en
P1476
A Phase II Trial of Bevacizuma ...... a of the Cervix or Endometrium
@en
P3098
NCT03476798
P4844
P580
2018-06-29T00:00:00Z
P582
2021-02-01T00:00:00Z